Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
2.090
-0.150 (-6.70%)
Nov 4, 2024, 4:00 PM EST - Market closed

Evogene Revenue

Evogene had revenue of $914.00K in the quarter ending June 30, 2024, with 39.76% growth. This brings the company's revenue in the last twelve months to $9.45M, up 290.29% year-over-year. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.

Revenue (ttm)
$9.45M
Revenue Growth
+290.29%
P/S Ratio
n/a
Revenue / Employee
$66,542
Employees
142
Market Cap
11.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019753.00K-994.00K-56.90%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cosmos Health 56.45M
STRATA Skin Sciences 32.73M
ImmunoPrecise Antibodies 17.44M
Vivos Therapeutics 14.02M
Apollomics 2.10M
Biora Therapeutics 860.00K
Revenue Rankings